Amrize (NYSE:AMRZ) Given New $58.00 Price Target at Wells Fargo & Company

Amrize (NYSE:AMRZFree Report) had its target price decreased by Wells Fargo & Company from $65.00 to $58.00 in a research report released on Wednesday morning, MarketBeat Ratings reports. Wells Fargo & Company currently has an overweight rating on the stock.

Other analysts also recently issued reports about the company. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Amrize in a research report on Friday, June 26th. Sanford C. Bernstein reiterated an “outperform” rating on shares of Amrize in a research note on Monday, June 22nd. Weiss Ratings lowered shares of Amrize from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, May 18th. Vertical Research upgraded shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 price target on the stock in a research note on Friday, May 1st. Finally, Truist Financial reiterated a “hold” rating and set a $48.00 price objective (down from $65.00) on shares of Amrize in a research note on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and seven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Amrize currently has an average rating of “Moderate Buy” and a consensus target price of $63.00.

Get Our Latest Stock Report on Amrize

Amrize Trading Down 2.9%

NYSE AMRZ opened at $49.48 on Wednesday. The business has a fifty day simple moving average of $52.91 and a 200 day simple moving average of $55.56. The firm has a market capitalization of $27.37 billion and a P/E ratio of 23.67. The company has a current ratio of 1.40, a quick ratio of 0.89 and a debt-to-equity ratio of 0.38. Amrize has a 12 month low of $44.12 and a 12 month high of $65.94.

Amrize (NYSE:AMRZGet Free Report) last announced its earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). The business had revenue of $2.18 billion during the quarter. Amrize had a return on equity of 9.84% and a net margin of 9.70%.The company’s quarterly revenue was up 4.7% on a year-over-year basis. On average, analysts predict that Amrize will post 2.75 EPS for the current fiscal year.

Amrize Cuts Dividend

The company also recently disclosed a dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, May 12th. Amrize’s dividend payout ratio is 21.05%.

Insider Transactions at Amrize

In related news, insider Mario Gross acquired 2,800 shares of Amrize stock in a transaction dated Tuesday, May 19th. The shares were purchased at an average cost of $49.17 per share, with a total value of $137,676.00. Following the completion of the purchase, the insider owned 33,747 shares of the company’s stock, valued at $1,659,339.99. This represents a 9.05% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CTO Roald Brouwer acquired 1,500 shares of the firm’s stock in a transaction dated Thursday, May 21st. The stock was bought at an average price of $49.84 per share, for a total transaction of $74,760.00. Following the acquisition, the chief technology officer owned 19,757 shares of the company’s stock, valued at approximately $984,688.88. This trade represents a 8.22% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last quarter, insiders purchased 54,920 shares of company stock valued at $2,717,429. 0.54% of the stock is currently owned by corporate insiders.

Institutional Trading of Amrize

A number of institutional investors have recently made changes to their positions in the stock. Caldwell Sutter Capital Inc. grew its stake in shares of Amrize by 11.5% in the first quarter. Caldwell Sutter Capital Inc. now owns 2,675 shares of the company’s stock worth $150,000 after purchasing an additional 275 shares during the last quarter. Rothschild Investment LLC grew its position in shares of Amrize by 4.3% in the 4th quarter. Rothschild Investment LLC now owns 6,835 shares of the company’s stock worth $370,000 after buying an additional 280 shares during the last quarter. Baldwin Investment Management LLC increased its stake in shares of Amrize by 4.4% during the fourth quarter. Baldwin Investment Management LLC now owns 8,980 shares of the company’s stock valued at $486,000 after buying an additional 375 shares during the period. Mengis Capital Management Inc. increased its stake in shares of Amrize by 8.5% during the fourth quarter. Mengis Capital Management Inc. now owns 5,750 shares of the company’s stock valued at $311,000 after buying an additional 450 shares during the period. Finally, Itau Unibanco Holding S.A. lifted its stake in Amrize by 150.0% in the fourth quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock worth $41,000 after acquiring an additional 450 shares during the period.

Amrize Company Profile

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Read More

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.